- Home
- CMPX vs CYBN Comparison
CMPX vs CYBN Comparison
Compare CMPX & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- CYBN
- Stock Information
- Founded
- CMPX 2014
- CYBN 2019
- Country
- CMPX United States
- CYBN Canada
- Employees
- CMPX N/A
- CYBN N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- CMPX Health Care
- CYBN Health Care
- Exchange
- CMPX Nasdaq
- CYBN Nasdaq
- Market Cap
- CMPX 214.6M
- CYBN 177.9M
- IPO Year
- CMPX N/A
- CYBN N/A
- Fundamental
- Price
- CMPX $2.92
- CYBN $9.09
- Analyst Decision
- CMPX Strong Buy
- CYBN Strong Buy
- Analyst Count
- CMPX 6
- CYBN 3
- Target Price
- CMPX $12.50
- CYBN $111.50
- AVG Volume (30 Days)
- CMPX 1.4M
- CYBN 350.4K
- Earning Date
- CMPX 03-20-2025
- CYBN 02-28-2025
- Dividend Yield
- CMPX N/A
- CYBN N/A
- EPS Growth
- CMPX N/A
- CYBN N/A
- EPS
- CMPX N/A
- CYBN N/A
- Revenue
- CMPX $850,000.00
- CYBN N/A
- Revenue This Year
- CMPX N/A
- CYBN N/A
- Revenue Next Year
- CMPX $613.39
- CYBN N/A
- P/E Ratio
- CMPX N/A
- CYBN N/A
- Revenue Growth
- CMPX N/A
- CYBN N/A
- 52 Week Low
- CMPX $0.77
- CYBN $6.50
- 52 Week High
- CMPX $4.08
- CYBN $19.84
- Technical
- Relative Strength Index (RSI)
- CMPX 48.30
- CYBN 41.61
- Support Level
- CMPX $3.14
- CYBN $9.08
- Resistance Level
- CMPX $3.85
- CYBN $10.59
- Average True Range (ATR)
- CMPX 0.33
- CYBN 0.67
- MACD
- CMPX -0.11
- CYBN -0.04
- Stochastic Oscillator
- CMPX 5.68
- CYBN 13.76
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.